MRAM Overview

Analyst Rating Changes: Several Wall Street analysts have adjusted their price targets and ratings for various companies, including Piper Sandler lowering SITE Centers' target from $12 to $10 while maintaining an Overweight rating.

Upgrades and Downgrades: Notable upgrades include Leerink Partners raising Eli Lilly's target from $886 to $1,104 and upgrading the stock from Market Perform to Outperform, while Stifel downgraded Trex Company from Buy to Hold, cutting its target from $61 to $35.

Price Target Increases: Companies like Genmab and Everspin Technologies saw their price targets increased by HC Wainwright & Co. and Needham, respectively, with Genmab's target rising from $40 to $41 and Everspin's from $8 to $10.5.

Significant Cuts: Rothschild & Co. significantly reduced HubSpot's price target from $610 to $450, downgrading it from Buy to Neutral, while Morgan Stanley cut Norwegian Cruise Line's target from $27 to $25, maintaining an Equal-Weight rating.

Strategic Collaboration: Quintauris and Everspin Technologies have partnered to enhance memory solutions for RISC-V-based platforms, focusing on automotive, industrial, and edge applications that require high reliability and safety.

Integration of Technologies: The collaboration will integrate Everspin's MRAM technologies with Quintauris' architectures to ensure memory subsystems meet performance and safety standards, addressing critical challenges in safety-driven markets.

New Leadership Appointment: Everspin Technologies has appointed Sean Dougherty as Vice President of Sales, leveraging his extensive semiconductor experience to drive sales strategy and growth while ensuring customer satisfaction.

Strategic Focus Shift: David Schrenk will now concentrate solely on Business Development, reflecting Everspin's ambition to enhance both sales execution and strategic partnerships for future growth.